openPR Logo
Press release

Autoimmune Disease Therapeutics Market Trend to 2025 | Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG

04-09-2019 05:40 AM CET | Health & Medicine

Press release from: Big Market Research

Autoimmune Disease Therapeutics

Autoimmune Disease Therapeutics

The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025.

Immune system disorders occur due to low activity or over activity of the immune system.

An autoimmune disease is a condition in which the immune system mistakenly attacks and damages its own tissues. There are more than 80 different autoimmune diseases exist. Some of the common types of autoimmune diseases are rheumatoid arthritis (RA), psoriasis/psoriatic arthritis, multiple sclerosis, systemic lupus erythematosus (lupus), inflammatory bowel disease, and others.

Request for a sample copy of this report @ https://www.bigmarketresearch.com/request-sample/2955688/?utm_source=SBL

Autoimmune disease therapeutics are expected to experience significant market growth during the forecast period owing to early diagnosis of the disease, recent launch of advanced therapeutics, and rise in incidence of autoimmune disease. Furthermore, strong presence of late-stage pipeline drugs such as tocilizumab, baricitinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others. On the other side higher cost associated with the advanced therapeutics is expected to hamper the market growth.

The global autoimmune disease therapeutics market is segmented based on drug class, indication, sales channel, and region. Based on drug class, the market is classified as anti-inflammatory, antihyperglycemics, NSAIDs, interferons, and others. On the basis of indication, rheumatic disease, type 1 diabetes, multiple sclerosis, rare disease, inflammatory bowel disease, and other indications. According to the sales channel, the market is categorized as hospital pharmacy, drug stores & retail pharmacy, and online store. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, and rest of LAMEA).

Enquiry Before Buying @ https://www.bigmarketresearch.com/purchase-enquiry/2955688/?utm_source=SBL

The major players profiled in this study include: Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis AG, Pfizer Inc and UCB S.A.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.) Biogen Inc., EMD Serono Inc., GlaxoSmithKline plc, Shire Plc., Teva Pharmaceutical Industries Ltd.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Autoimmune Disease Therapeutics Market Key Segments:

By Drug Class: Anti-inflammatory, Antihyperglycemics, NSAIDs, Interferons and Others

By Indication: Rheumatic Disease, Type 1 Diabetes, Multiple Sclerosis, Rare Disease, Inflammatory Bowel Disease and Other Indications

By Sales Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Stores

By Country:

North America: U.S., Canada, Mexico

Europe: UK, Germany, France, Spain, Italy, Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific

LAMEA: Chile, Israel, South Africa, Rest of LAMEA

Access Full Summery @ https://www.bigmarketresearch.com/autoimmune-disease-therapeutics-market/?utm_source=SBL

Similar Publisher Related report:

Global Autoimmune Disease Therapeutics Market Data Survey Report 2025

More summary: https://www.bigmarketresearch.com/global-autoimmune-disease-therapeutics-market-data-survey-report-2025-market/?utm_source=RR&utm_medium=SBL

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact Us:

Mr. Abhishek Paliwal

 5933 NE Win Sivers Drive, #205, Portland,

 OR 97220 United States

 call answer Direct:+1-971-202-1575

 call answer Toll Free:+1-800-910-6452

 email help@bigmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Therapeutics Market Trend to 2025 | Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG here

News-ID: 1693994 • Views: 818

More Releases from Big Market Research

Transient Elastography Devices Market 2020 Analyzed by Top Key Players Echosens, …
Big Market Research provides a detailed overview of Transient Elastography Devices Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Transient Elastography Devices market in conjunction with the geographical landscape, demand spectrum, remuneration scale, and growth graph of this vertical have also been included during this report. This report is a professional and thorough research of the world Transient Elastography Devices
Augmented Reality in Retail Market Emerging Trends, Global Demand and Top Brands …
Global Augmented Reality in Retail Market is valued approximately at USD 10.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 46.6% over the forecast period 2020-2027. The Augmented Reality in Retail Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2027. The Augmented Reality in Retail market report is a valuable source of data for business strategists. It provides the industry
Aseptic Sampling Market in Global Industry: Demands, Insights, Research and Fore …
Global Aseptic Sampling Market is valued approximately USD 0.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.10 % over the forecast period 2020-2027. Big Market Research provides a detailed overview of Aseptic Sampling Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Aseptic Sampling market in conjunction with the geographical landscape,
3D Motion Capture System Market in Global Industry: Demands, Insights, Research …
The research report on 3D Motion Capture System Market thoroughly investigates historical data of this business sphere to lay out the future roadmap of the industry. The study attempts to predict a long-term picture of the market scenario with respect to the various growth indicators, hindrances, and opportunities that determine the industry expansion. Moreover, the report provides an exhaustive synopsis of the industry at a global and regional level. In

All 5 Releases


More Releases for Disease

Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased
Crohns Disease Treatment Market
Crohn’s disease is a chronic inflammatory bowel syndrome that causes inflammation in the gastrointestinal tract. Inflammation can take place anywhere between mouth to anus. It commonly affects end of small intestine (Ileum) and beginning of the colon. Common symptoms of Crohn’s disease from mild to severe intensity include abdominal pain, frequent diarrhea, reduced appetite, and fever. Sometimes rectal bleeding is also observed due to fissures from inflammation at anal canal.
Peyronie’s Disease Treatment Market
Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. This condition can cause painful erections and the penis gets bent while it is erected. The bent is towards the side where plaque is being formed i.e. either downwards or upwards. The condition is identified by a major bend or pain. In a few people
Global Gaucher Disease Treatment Market
Gaucher disease is recessive gene dominance disorder with massive clinical heterogeneity. Symptoms of the disease include painless splenomegaly, anemia, or thrombocytopenia, chronic fatigue, hepatomegaly, bone pain, and pathologic fractures. The disease also contributes to easy incidence of bruising and bleeding through the nose. Manifested in three sub-types, the disease results from the deficiency of the enzyme glucocerebrosidase. It is the most common lysosomal storage disorder and has an incidence of
Otava Alzheimer’s Disease Targeted Libraries
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD. But there is no cure for AD and no treatment to reverse its progression, there are medicines available that can help treat symptoms in some people with this disease. Intensive scientific research around the world brings us closer to
Cardiovascular Disease Prevention
Reduce Your Risk of Cardiovascular Disease… Useful information about how you can lower your blood pressure, lower cholesterol, and decrease your risk of heart disease. One person dies every 30 seconds from heart disease. That's over 2,600 people every single day!! Cardiovascular disease refers to any disorder in any of the various parts of your cardiovascular system, which includes your heart and blood vessels. The heart is the